ClinicalTrials.gg
Enrolling by invitationNCT07560371MBCRCTUpdated Jun 3, 2026

Evaluating a Mindfulness Booster Course for Healthcare Staff

An interventional study of Mindfulness Booster Course and Usual Care in Occupational Stress or Workplace Stress, sponsored by Canterbury Christ Church University. Enrolling by invitation at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-03.

Sponsored by Canterbury Christ Church University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
186
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Occupational Stress with a site in United Kingdom — 3 open to participants now, 3 under way, none of them phase 3. Occupational Stress · United Kingdom.

Started
2026
the only one that year
No phase
7 of 11
3 open now
Registered
11th of 11
by date
Lead sponsor
1 of 11
Canterbury Christ Church University

Among the 11 studies in Occupational Stress with a site in United Kingdom, this one is the only one that started in 2026, is one of 7 with no phase, and was the 11th registered.

Occupational Stress

238 studies on the registry are indexed under Occupational Stress; 64 are open to participants now.

Browse Occupational Stress studies →

Open to participants now

3 of the 11 studies in Occupational Stress with a site in United Kingdom are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 33 Occupational Stress studies recruiting now, 17 (52%) set no upper age limit and 13 (39%) stop at 75 or younger; 4 take children under 18; 25 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Occupational Stress with a site in United Kingdom, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if a mindfulness booster course can reduce stress in healthcare staff who have previously attended a mindfulness course. The main questions it aims to answer are:

  • Is a mindfulness booster course for healthcare staff effective at reducing their stress levels?
  • Are any benefits maintained for 8 weeks?

Researchers will compare a mindfulness booster course with usual care to see if it helps to reduce stress. Participants will take part in either a mindfulness booster course or do what they usually do to look after their wellbeing. They will complete questionnaires at the beginning, middle and end of the study.

Read the detailed description

Aims:

  1. To determine whether the mindfulness booster course for healthcare staff is effective in terms of the primary outcome (perceived stress) and secondary outcomes (wellbeing, depression, burnout, and compassion for others), and whether any benefits are maintained at follow-up.
  2. To examine whether any effects on the above-mentioned outcomes are statistically mediated by changes in amount of mindfulness practice, rumination and worry, decentering, self-compassion, and trait mindfulness.
  3. To develop an abbreviated grounded theory of the therapeutic process and outcomes of the mindfulness booster course.

Hypotheses:

  1. a) The primary hypothesis is that we will see a significantly greater decrease in the primary outcome of perceived stress at post-intervention (the primary time-point of Weeks 11-12) relative to baseline (Weeks 0-1) for the 'mindfulness-booster course plus treatment as usual (TAU)' intervention group compared to the 'TAU-only' control group.

    b) Our secondary hypothesis is that we will see significantly greater improvements in each of our secondary outcome measures at post-intervention (Weeks 11-12) relative to baseline for our intervention group compared to our control group. Improvements entail decreases in depression and burnout and increases in compassion for others and wellbeing.

    c) Our third hypothesis is that we will also see the effects detailed in (1a) and (1b) above at the follow-up time-point (Weeks 19-20).

  2. a) The relationship between group allocation (intervention vs. control) and reduction in perceived stress, from baseline to follow-up (Weeks 19-20), will be statistically mediated by changes from baseline to post-intervention in the following psychological constructs: i) increase in amount of mindfulness practice, both formal and informal; ii) reduction in rumination and worry, i.e., repetitive negative thinking; iii) increase in decentering; iv) increase in self-compassion; v) increase in trait mindfulness.

    b) The relationships specified in Hypothesis 2a will also hold true for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others).

    c) i) The relationship between group allocation and reduction in perceived stress will be serially statistically as follows: intervention group allocation predicts increased mindfulness practice (from baseline to post-intervention [Weeks 11-12]) which in turn predicts change in psychological mechanisms (i.e., rumination/worry, decentering, self-compassion and trait mindfulness; from baseline to post-intervention [Weeks 11-12]), which in turn predict reduced perceived stress (from baseline to follow-up [Weeks 19-20]).

    ii) The relationships specified in Hypothesis 2c-i will also hold for the secondary outcomes (i.e. change from baseline to follow-up [Weeks 19-20] in wellbeing, depression, burnout and compassion for others).

    Design Information Not Included Elsewhere in this Registration:

    After Weeks 11-12, a subsample of intervention group participants will be invited to participate in a semi-structured individual interview, with the qualitative data being collected and analysed according to grounded theory principles. This aspect of the study has the following sub-aims:

    1. To explore what processes occur during the mindfulness booster course, based on participants' experiences.
    2. To explore how these processes interact with the participants' contexts, including, but not limited to, working in healthcare.
    3. To explore how these processes and contexts interact with, and perhaps drive, any perceived impacts and outcomes of the course.
03

Conditions studied

  • Occupational Stress or Workplace Stress

Browse trials for

Keywords

  • booster course
  • mindfulness
  • health personnel
  • perceived stress
  • health care workers
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • UK National Health Service staff member.
  • Has completed an 8-week mindfulness course (either MBCT, MBCT-L or MBSR). Individuals will be considered to have "completed" a mindfulness course if they attended four or more sessions.
  • Is able to make one of the planned sets of times for the booster course sessions, in case they are randomly allocated to the intervention arm.

Exclusion criteria

Exclusion Criteria:

  • Currently on sick leave.
  • Planning on undertaking another 8-week mindfulness course.
  • Previously participated in the mindfulness booster course in the feasibility study.
  • Have previously found practising mindfulness distressing.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
186 participants (estimated)

Study arms

  • Experimental
    Mindfulness Booster Course

    Behavioral: Mindfulness Booster Course · Behavioral: Usual Care

  • Other
    Treatment as usual control

    Behavioral: Usual Care

Interventions

  • BehavioralMindfulness Booster Course

    The mindfulness booster course will consist of eight 30-minute sessions, which participants will be asked to commit to. These will be online and usually occur weekly. Within these sessions, there will be a 15-minute mindfulness practice followed by a 15-minute discussion. This discussion time will involve reflecting on the mindfulness practice and speaking about between-session practice. Participants will be encouraged to practice mindfulness for home work between the sessions.

  • BehavioralUsual Care

    Participants will be encouraged to continue with whatever activities they usually undertake to manage their stress and support their wellbeing.

06

What researchers measure

Primary outcomes

  1. Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 11-12.

    The 10-item Perceived Stress Scale (PSS-10) is a self-report measure of perceived stress, which produces a score ranging between 0 and 40. A higher score indicates greater perceived stress.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12

Secondary outcomes

  1. Change in Perceived Stress Scale score from baseline (Weeks 0-1) at Weeks 19-20.

    The 10-item Perceived Stress Scale (PSS-10) is a self-report measure of perceived stress, which produces a score ranging between 0 and 40. A higher score indicates greater perceived stress.

    Time frame: Baseline (Weeks 0-1) and Weeks 19-20

  2. Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 11-12.

    The 8-item Patient Health Questionnaire (PHQ-8) is a self-report measure of depression, which produces a score ranging between 0 and 24. A higher score indicates a greater level of depression symptoms.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  3. Change in 8-item Patient Health Questionnaire score from baseline (Weeks 0-1) at Weeks 19-20.

    The 8-item Patient Health Questionnaire (PHQ-8) is a self-report measure of depression, which produces a score ranging between 0 and 24. A higher score indicates a greater level of depression symptoms.

    Time frame: Baseline (Weeks 0-1) and Weeks 19-20

  4. Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 11-12.

    The Brief Sussex-Oxford Compassion for Others Scale (SOCS-O) is a 5-item, self-report measure of compassion for others, which produces a score ranging between 5 and 25. A higher score indicates greater compassion for others.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  5. Change in Brief Sussex-Oxford Compassion for Others Scale score from baseline (Weeks 0-1) at Weeks 19-20.

    The Brief Sussex-Oxford Compassion for Others Scale (SOCS-O) is a 5-item, self-report measure of compassion for others, which produces a score ranging between 5 and 25. A higher score indicates greater compassion for others.

    Time frame: Baseline (Weeks 0-1) and Weeks 19-20

  6. Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 11-12.

    The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) is a 7-item self-report measure of mental wellbeing, which produces a score ranging between 7 and 35. A higher score indicates a greater level of mental wellbeing.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  7. Change in Short Warwick-Edinburgh Mental Wellbeing Scale score from baseline (Weeks 0-1) at Weeks 19-20.

    The Short Warwick-Edinburgh Mental Wellbeing Scale (SWEMWBS) is a 7-item self-report measure of mental wellbeing, which produces a score ranging between 7 and 35. A higher score indicates a greater level of mental wellbeing.

    Time frame: Baseline (Weeks 0-1) and Weeks 19-20.

  8. Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 11-12.

    The Sussex Burnout Scale (SBS) is a 3-item self-report measure of burnout, which produces a score ranging between 3 and 15. A higher score indicates a greater level of burnout.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  9. Change in Sussex Burnout Scale score from baseline (Weeks 0-1) at Weeks 19-20.

    The Sussex Burnout Scale (SBS) is a 3-item self-report measure of burnout, which produces a score ranging between 3 and 15. A higher score indicates a greater level of burnout.

    Time frame: Baseline (Weeks 0-1) and Weeks 19-20.

Other outcomes

  1. Change in the 15-item Five-Facet Mindfulness Questionnaire from baseline (Weeks 0-1) at Weeks 11-12.

    The 15-item Five-Facet Mindfulness Questionnaire (FFMQ-15) is a self-report measure of mindfulness, which produces a score ranging between 15 and 75. A higher score indicates a greater level of mindfulness.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  2. Change in the Brooding Subscale of the Ruminative Response Scale from baseline (Weeks 0-1) at Weeks 11-12.

    The 5-item Brooding Subscale of the Ruminative Response Scale (RRS-B) is a self-report measure of brooding rumination, which produces a score ranging between 5 and 20. A higher score indicates a greater level of brooding rumination.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  3. Change in the 8-item version of the Penn State Worry Questionnaire from baseline (Weeks 0-1) at Weeks 11-12.

    The 8-item Penn State Worry Questionnaire (PSWQ-A) is a self-report measure of worry, which produces a score ranging between 8 and 40. A higher score indicates a greater level of worry.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  4. Change in the Decentering Scale of the Experiences Questionnaire from baseline (Weeks 0-1) at Weeks 11-12.

    The 11-item Decentering Scale of the Experiences Questionnaire (EQ-D) is a self-report measure of decentering, which produces a score ranging between 11 and 55. A higher score indicates a greater ability to decenter.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  5. Change in Brief Sussex-Oxford Compassion to Self Scale score from baseline (Weeks 0-1) at Weeks 11-12.

    The Brief Sussex-Oxford Compassion to Self Scale (SOCS-S) is a 5-item, self-report measure of compassion for the self, which produces a score ranging between 5 and 25. A higher score indicates greater compassion towards oneself.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

  6. Change in the average amount of time spent practicing mindfulness from baseline (Weeks 0-1) at Weeks 11-12.

    A bespoke, self-report questionnaire will measure the amount of mindfulness practice undertaken, on average, per week, in minutes. Separate averages will be calculated for formal and informal mindfulness practice.

    Time frame: Baseline (Weeks 0-1) and Weeks 11-12.

07

Study locations

1 site
  • Sussex Mindfulness Centre
    Worthing, West Sussex BN11 1HS, United Kingdom
08

References and documents

Individual participant data

Plan to share: Yes — All outcome measure IPD will be made publicly available. Some or all demographic IPD may be excluded to prevent jigsaw identification of participants. An assessmment of what, if any, demographic IPD can be included will be made once the data have been collected and the risk of participant identification assessed.

Supporting information: Study protocol

Time frame: These will be made available after the study findings have been published in peer reviewed journals and, in any event, no more than 3 years after study completion.

Access criteria: These will be made publicly available on the internet at access at https://pure.canterbury.ac.uk/en/persons/fergal-jones-2/

Data sharing details ↗ · pure.canterbury.ac.uk

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Mar 2027, 10 months after the start.

Of 128 non-industry interventional studies with no phase under Occupational Stress, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 27. This study's planned 10 months is close to that.

Counting every sponsor, half of 136 studies reached it within 10 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2026
First posted
May 1, 2026
StartActual
May 13, 2026
Primary completionEst.
Mar 2027
CompletionEst.
May 2027
Last update
Jun 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07560371
Lead sponsor
Canterbury Christ Church University
Collaborators
Sussex Partnership NHS Foundation Trust
Responsible party
Sponsor
First posted
May 1, 2026
Start date
May 13, 2026
Primary completion
Mar 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Jun 3, 2026

Study contacts

Fergal W Jones, PhD, PsychD
principal investigator · Canterbury Christ Church University & Sussex Partnership NHS Foundation Trust
Clara Strauss, PhD, DClinPsychol
study chair · Sussex Partnership NHS Foundation Trust & University of Sussex
Becky Pearse, BA, MSc
study director · Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust
Becky Pfaff, BSc, MSc
study director · Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust
Lila Maleviti, BSc, MSc
study director · Canterbury Christ Church University & Surrey and Borders Partnership NHS Foundation Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion